US10174011, aripiprazole US10752588, Compound Aripiprazole US11498896, Compound Aripiprazole 7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one CHEMBL1112 US9156822, Aripiprazole BDBM50130293 US9018213, aripprazole ARIPIPRAZOLE
- Shapiro, DA; Renock, S; Arrington, E; Chiodo, LA; Liu, LX; Sibley, DR; Roth, BL; Mailman, R Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 28: 1400-11 (2003)
- Lawler, CP; Prioleau, C; Lewis, MM; Mak, C; Jiang, D; Schetz, JA; Gonzalez, AM; Sibley, DR; Mailman, RB Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology 20: 612-27 (1999)
- Vangveravong, S; Zhang, Z; Taylor, M; Bearden, M; Xu, J; Cui, J; Wang, W; Luedtke, RR; Mach, RH Synthesis and characterization of selective dopamine D2 receptor ligands using aripiprazole as the lead compound. Bioorg Med Chem 19: 3502-11 (2011)
- Zajdel, P; Marciniec, K; Maslankiewicz, A; Grychowska, K; Satala, G; Duszynska, B; Lenda, T; Siwek, A; Nowak, G; Partyka, A; Wróbel, D; Jastrzebska-Wiesek, M; Bojarski, AJ; Wesolowska, A; Pawlowski, M Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT1A/5-HT2A/5-HT7 and dopamine D2/D3 receptors. Eur J Med Chem 60: 42-50 (2013)